Grifols Engineering to build a plasma fractionation plant in Egypt

Grifols and the Egyptian Government, through the National Service Projects Organization (NSPO), have signed a strategic agreement to develop the plasma medicine market in the country and promote its self-sufficiency.

The agreement has been formalized through the incorporation of a joint venture company owned by NSPO (51%) and Grifols (49%). The transaction will enable the Egyptian health service to be strengthened and to meet the needs of the country.

Plasma fractionation plant

Both parties will combine their industrial experience and financial efforts to design, build and start up 20 plasma donation centres in Egypt with an initial capacity to obtain 600,000 litres of plasma per year, as well as production facilities that include:

  • A fractionation plant (with capacity to fractionate up to 1 million litres of plasma per year, expandable to 2 million). 
  • A purification and dosing plant.
  • A warehouse.
  • A testing laboratory.

Grifols Engineering will be commissioned with managing the construction and start-up of the production facilities on land covering 105,000.00 m², in the New Capital area.

The plasma donation centers and facilities are expected to be functioning by the end of 2025.